A phase II study of continuous infusional 5-fluorouracil (5-FU) and subcutaneous interleukin-2 (IL-2) in metastatic renal cancer

European Journal of Cancer Part A

Volumn 33, Issue 7, 1997, Pages 1149-1151

  Savage, P ^a   Costelna, D ^a   Moore, J ^a   Gore, M E ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Cancer; Chemotherapy; Immunotherapy; Interleukin 2; Therapeutics

Indexed keywords

FLUOROURACIL; INTERLEUKIN 2;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; EDEMA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INOTROPISM; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY CANCER; MALAISE; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; INTERLEUKIN-2; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; REMISSION INDUCTION;

EID: 0030859233     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(96)00515-1     Document Type: Article

References (9)

1. Fossa S, Jones M, Johnson P, et al. Interferon-alpha and survival in renal cell cancer. Br J Urol 1995, 76, 286-290.
2. Jones M, Philip T, Palmer P, et al. The impact of interleukin-2 on survival in renal cancer: a multivariate analysis. Cancer Biother 1993, 8, 275-288.
3. Atzpodien J, Korfer A, Franks CR, Poliwoda H, Kirchner H. Home therapy with recombinant interleukin-2 and interferon-gamma2b in advanced human malignancies. Lancet 1990, 335, 1509-1510.
4. Atzpodien J, Kirchner H, Lopez-Hanninen E, Deckert M, Fenner M, Poliwoda H. Interleukin-2 in combination with interferon alpha and 5-fluorouracil for metastatic renal cell cancer. Eur J Cancer 1993, 29A(Supp. 5), S6-S8.
5. Lokich JJ, Ahlgren JD, Gullo JJ, Phillips JA, Fryer JG. A prospective randomised comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a mid-Atlantic Oncology Program study. J Clin Oncol 1989, 7, 425-432.
6. Findlay M, Cunningham D, Norman A, et al. A phase II study in advanced gastro-esophageal cancer using epirubicin and cistplatin in combination with continuous infusion 5-fluorouracil (ECF). Ann Oncol 1994, 5, 609-616.
7. WHO. Handbook for Reporting Results of Cancer Treatment. WHO offset publication no. 48, Geneva, World Health Organisation, 1979.
8. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981, 47, 207-214.
9. Lotze MT, Chan AE, Seipp CA, Simpson C, Vetto JT, Rosenberg SA. High dose recombinant interleukin-2 in the treatment of patients with disseminated cancer: responses, treatment-related morbidity and histological findings. JAMA 1986, 256, 3117-3124.